Tag Archives: National Institutes of Health

Race to Develop H1N1 Vaccine

Execs from Inovio Biomedical Corporation and Novavax will be speaking at BIF about their experience in the race to develop a vaccine for H1N1. Below are a couple recent developments from these companies: Novavax Inc (NVAX.O) recently reported that its seasonal flu vaccine candidate, which uses virus-like particles, induced an immune response against H3N2, H1N1 and B and was well-tolerated in a mid-stage trial. Read the release. Inovio Biomedical Corp. (INO) said it will team up Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

GAO Report on Bayh-Dole: Leverage to Promote Commercialization of Federally-Funded Inventions

The General Accountability Office submitted its report to Congress today on the administration of the regulations found under the Bayh-Dole Act, the foundation of all federally-funded research in the United States and one of the key factors in the creation (and boom) of biotechnology as both a research field and industry in the 1980s. A little background on Bayh-Dole: Technological innovation is widely seen as responsible for much of the economic growth and increased standard Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

For July 4: Let’s Thank the Inventors

My hope for America this July 4? I hope, in 100 years, the response time to human and environmental suffering will be immediate. Until that day arrives (thanks to scientific breakthroughs funded by individual citizens) — let’s thank our scientists, investors, and inventors who work and play around us.

Finally, let’s also thank the founding fathers for knowing America’s innovative potential without seeing it for themselves.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

For U.S. Healthcare Reform and Global Health Crises, Both Public and Private Efforts Needed

How can we address health needs in both the United States and developing countries at the same time? By bringing everyone to the table for open, fair, collaborative partnerships. It saves money, time, effort and – most important of all – lives.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

A Stimulated NIH Discovers the Devil in the Grant Details

This blog post discusses the opportunities for growth created by the 2009 NIH stimulus funds.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,